UPCOMING DATES

August 21-23, 2019  •  November 6-8, 2019
January 29-31, 2020   •   April 1-3, 2020

Musculoskeletal Ultrasound Training for Hemophilia and Other Arthritic Conditions, presented by UC San Diego School of Medicine, is a 3-day hands-on course developed to provide training in musculoskeletal ultrasound (MSKUS) for evaluation of hemophilic joint disease, but also other arthritic conditions and musculoskeletal abnormalities and syndromes. The main objective of the course is to enable physicians and other care providers to use MSKUS as a point-of-care imaging tool to assist with the diagnosis and treatment of joint pains. In addition, the course has specific elements geared towards hemophilic joint disease to recognize joint bleeding, synovial hypertrophy and synovitis, cartilage degradation, osteochondral lesions and other structural joint abnormalities. The course also includes a teaching module pertaining to the Joint Tissue Activity and Damage Exam (JADE), a validated ultrasound imaging protocol for hemophilic joints.

Leading MSK ultrasound experts will cover ultrasound scanning, sonoanatomy, and sonopathology through interactive lectures, case presentations, round table discussions, and advanced MSKUS imaging techniques including MSKUS examination of hemophilic joints. This program is currently the only hands-on scanning course that provides comprehensive training sections and experience in musculoskeletal ultrasound in hemophilia.

This program is offered several times annually, and is held in San Diego, California at the UC San Diego Health Hemophilia & Thrombosis Treatment Center at UC San Diego Health.

Registrants for the Musculoskeletal Ultrasound Training for Hemophilia and Other Arthritic Conditions live course are encouraged to complete web modules 1, 2, 4, and 5 prior to attending the activity (a total of 2 hours of web-based instruction).

If you would like to extend your learning experience, we offer an additional program, UltrasoundGuided Joint Injection and Aspiration for Arthritic Conditions and Hemophilia, that is held upon the conclusion of the main 3-day course.

Target Audience

This educational program is designed for any health care provider, but in particular for physicians, physician assistants, nurse practitioners, nurses, and physical therapists involved and/or interested in MSKUS as a point-of-care imaging tool to assist with diagnosis and treatment of joint and muscle pains in patients or people with and without hemophilia. Athletic trainers may also benefit from this course. Pediatric practitioners are welcomed. While ultrasound techniques for adults and children are similar, readings mainly apply to adolescents and adults with a mature skeleton. To complete pediatric training we refer to the online module Pediatric Considerations for the Use of Musculoskeletal Ultrasound in Hemophilia.

Objectives

Upon completion of this activity, participants should be able to:

  • Describe MSKUS basics, basic physics and knobology
  • Discuss the basic operations of an ultrasound machine
  • Interpret and apply sono-anatomy of ankles, knees, elbows, hip (including sacro-iliac joints), facette joints and shoulders
  • Interpret basic structural abnormalities by sono-pathological findings
  • Apply standard MSKUS transducer positions for ankles, knees, elbows hip (including sacro-iliac joints), facette joints and shoulders
  • Describe the Joint Tissue Activity and Damage Exam (JADE) Hemophilia joint ultrasound protocol
  • Describe the diagnosis of effusions
  • Distinguish bloody from non-bloody effusions
  • Perform a diagnostic musculoskeletal ultrasound recognizing hemarthrosis, synovitis and structural abnormalities (such as meniscus, tendons, ligaments)
  • Quantify synovitis by Power Doppler
  • Quantify cartilage health, soft tissue and synovial hypertrophy, and osteochondral lesions

UC San Diego Health Hemophilia and Thrombosis Treatment Center

The Hemophilia and Thrombosis Treatment Center has cared for patients with hemophilia since its founding in 1989. It later became one of approximately 130 federally funded Hemophilia Treatment Centers, with a mandate to reach out to all patients with hemophilia and other bleeding disorders in the community in order to improve and specialize their care, as well as to ensure and afford access to life-saving clotting factors.

The mission of the Hemophilia and Thrombosis Treatment Center is to provide state-of-the art care to our patients with a team of specialized and highly trained physicians, nurses, physical therapists and social workers. This includes:

  • Access to and appropriate use of clotting factors
  • All-around medical care focused on the needs of adolescent, adult, and aging patients with hemophilia, including care for hemophilic arthropathy, osteoporosis, cancer and cardiovascular disease. In addition, the center works closely with the Owen Clinic and the Liver Center to ensure that patients with hemophilia and HIV and/or hepatitis B and C virus receive appropriate treatment.
  • State-of the-art research for the hemophilia community, with opportunities to participate in clinical trials studying new long-lasting clotting factor products, bypassing agents for patients with inhibitors, as well as studying joint disease and cardiovascular disease in hemophilia. This effort has the ultimate goal to create new knowledge for patients with hemophilia, advance the field and improve care paradigms.

ISTH

EAHAD

UCSD CMEUCSD CME facebook UCSD CME twitter

Content is subject to change without notice. Please refer to the activity website for the most current information.

Official website of the University of California San Diego. Copyright ©2019 Regents of the University of California. All rights reserved.